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from studies if diagnostic scans revealed pathological long
bone fractures or cord compression. Beneﬁts of exercise
included increased lower body strength, perceived quality of
life, and adherence to training regimens when supervised by
an exercise physiologist or physical therapist. Select studies
also revealed a positive inﬂuence on body composition and
systolic blood pressure.
Discussions & Implications: Research supports that pa-
tients undergoing autologous hematopoietic stem cell
transplant for multiple myeloma beneﬁt from exercise.
However, there is room to explore the effect exercise has in
decreasing secondary complications that can occur following
HSCT. We plan on presenting these ﬁndings to leadership to
pursue development of an exercise program for our patients
with Multiple Myeloma pre-, during, and post-autologous
HSCT.566
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Cleveland Clinic performed 66 outpatient reduced intensity
transplants from 2009-2014. Of those patients 45 (68%) were
admittedwithin the ﬁrst 100 days of their transplant. 34 out of
66 (52%) of outpatient transplant patients from 2009-2014
were diagnosedwith a catheter related blood stream infection
and 18 (53%) were within the ﬁrst 100 days. Traditionally,
these patients have a triple lumenHickman (TLH) placed prior
to starting their preparative regimen that stays in place for the
duration of their treatment (Schiffer, 2013). Due to the
chemotherapy, immune suppressive medications, and central
lines, these patients are at higher risk of infection. Patients are
taught to maintain this line at home, which consists of
ﬂushing each lumen daily and changing the bandage and caps
weekly. If infections occur, patients are admitted to the hos-
pital for evaluation and treatment. Infections can increase this
patient population’s morbidity and mortality (Viscoli et al,
2005). Infections cost over $45,000 per case for the hospital
and patient (Schiffer, 2013). Increasing patient outcomes and
decreasing costs are goals of transplant programs, which may
be achieved by decreasing infection rates.
Methods, Intervention, & Analysis: A review of literature
indicated that subcutaneous ports instead of TLH have the
potential to decrease risk of infection though the body of
current literature does not include transplant patients. The
articles reviewed focused on oncology patients, pediatric and
adult, receiving chemotherapy.
Findings & Interpretation: The information analyzed in-
dicates strong evidence to support subcutaneous port use
instead of TLH in transplant patients but since no infor-
mation speciﬁcally looks at transplant patients, further
investigation is needed. Patients prefer ports due to low self-
maintenance which could decrease infections due to patient
adherence to line care. Some patients have ports in place
from prior therapy and therefore would not need a second
procedure to place TLH. Due to the reduced intensity of the
chemotherapy used in outpatient transplants, it is reason-
able to apply this change.Discussion & Implications: As of July 31, 2014, Cleveland
Clinic will use ports instead of TLH for the next 10 patients
receiving an outpatient allogeneic transplant. These patients
will be tracked for line infections and admission rates within
100 days after transplant.567
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Indications for stem cell transplantation (SCT) in the pediatric
population are increasing, and patients are expected to live
long and productive lives. However, they do require lifelong
follow up, dictated by the initial diagnosis and late toxicities.
Like most pediatric centers, patients over 21 years old can no
longer be followed by our pediatric team and need to be
transferred to an adult facility. At our institution, we are facing
the challenge of a lack of available resources to transfer all of
our patients to an adult transplant facility. In this situation,
how can we best provide patients with a proper and safe
follow-up when the adult transplant center cannot accept the
entire patient cohort?
Methods, Intervention, & Analysis: In order to achieve this
goal, we have developed a standardized protocol to direct
our patients toward the most appropriate facility. Referral to
the adult transplant team is restricted to those patients
presenting with GVHD, hematologic toxicity or more than
two organs’ involvement. All of our other patients, which
represent the vast majority, will be referred to their family
physician with speciﬁc guidelines. However, most of them
don’t have a family physician as the follow up of SCT patients
may seem complex.
Findings & Interpretation: First, our protocol will help
guide and support our patients in identifying a family
physician, which can take up to two years. Once a referring
doctor is found, the transplant physician and the nurse
navigator will prepare a ﬁle containing the patient medical
summary and guidelines detailing the recommended follow
up and possible long term sequelae. Also, our team remains
available to answer questions. Finally, we encourage family
physicians to send us periodical summary charts.
Discussion & Implications: Information about the recom-
mended follow up and good life habits are previously given
to patients to promote their autonomy and facilitate a
smooth transition. This procedure is an important part of our
teenagers transplant clinic that was just implemented. This
procedure started about a year ago, and so far, it seems to be
a positive experience for everyone involved.568
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